Based on limited published evidence, PRAMEF15 is a PRAME family member involved in protein degradation pathways. Structural annotations indicate it functions as a ubiquitin-like ligase-substrate adaptor within the Cul2-RING ubiquitin ligase complex, localizing to the cytoplasm where it participates in proteasome-mediated ubiquitin-dependent protein catabolism. In colorectal cancer genetics, PRAMEF15 mutations co-occur with TP53 mutations in primary tumors that develop metachronous liver metastases, suggesting potential involvement in cancer progression pathways 1.